Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Apoptosis in the development and treatment of cancer.

Gerl R, Vaux DL.

Carcinogenesis. 2005 Feb;26(2):263-70. Epub 2004 Sep 16. Review.

PMID:
15375012
2.

Apoptosis in tumorigenesis and cancer therapy.

McGill G, Fisher DE.

Front Biosci. 1997 Jul 15;2:d353-79. Review.

PMID:
9230063
3.

Apoptosis signaling in tumor therapy.

Fulda S, Debatin KM.

Ann N Y Acad Sci. 2004 Dec;1028:150-6. Review.

PMID:
15650241
4.

Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells.

Osford SM, Dallman CL, Johnson PW, Ganesan A, Packham G.

Curr Med Chem. 2004 Apr;11(8):1031-9. Review.

PMID:
15083809
5.

Apoptosis and cancer chemotherapy.

Makin G, Dive C.

Trends Cell Biol. 2001 Nov;11(11):S22-6. Review.

PMID:
11684438
6.

Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain.

Taylor K, Micha D, Ranson M, Dive C.

Expert Opin Investig Drugs. 2006 Jun;15(6):669-90. Review.

PMID:
16732718
7.

Apoptosis, cancer and cancer therapy.

Bold RJ, Termuhlen PM, McConkey DJ.

Surg Oncol. 1997 Nov;6(3):133-42. Review.

PMID:
9576629
8.

Therapeutic targeting of apoptosis pathways in cancer.

Ziegler DS, Kung AL.

Curr Opin Oncol. 2008 Jan;20(1):97-103. Review.

PMID:
18043263
9.

Targeting apoptosis pathways in cancer therapy.

Fulda S, Debatin KM.

Curr Cancer Drug Targets. 2004 Nov;4(7):569-76. Review.

PMID:
15578914
11.

Therapeutic targeting of apoptotic pathways in cancer.

Meiler J, Schuler M.

Curr Drug Targets. 2006 Oct;7(10):1361-9. Review.

PMID:
17073598
12.

Small-molecule BH3 mimetics to antagonize Bcl-2-homolog survival functions in cancer.

Goldsmith KC, Hogarty MD.

Curr Opin Investig Drugs. 2009 Jun;10(6):559-71. Review.

PMID:
19513945
13.

Death receptor signaling in cancer therapy.

Fulda S, Debatin KM.

Curr Med Chem Anticancer Agents. 2003 Jul;3(4):253-62. Review.

PMID:
12769771
14.

Apoptosis: the suicide solution in cancer treatment and chemoprevention.

Sykiotis GP, Papavassiliou AG.

Expert Opin Investig Drugs. 2006 Jun;15(6):575-7.

PMID:
16732712
15.

Apoptosis: future directions in cancer therapy.

Ravi D, Panikkar KR, Nair MK, Pillai MR.

Natl Med J India. 2000 Mar-Apr;13(2):71-8. Review.

PMID:
10835853
16.

Changes in the apoptotic and survival signaling in cancer cells and their potential therapeutic implications.

Kabore AF, Johnston JB, Gibson SB.

Curr Cancer Drug Targets. 2004 Mar;4(2):147-63. Review.

PMID:
15032666
17.
18.

Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model.

Hersey P, Zhuang L, Zhang XD.

Int Rev Cytol. 2006;251:131-58. Review.

PMID:
16939779
19.

Regulation of death receptors--relevance in cancer therapies.

de Thonel A, Eriksson JE.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):123-32. Review.

PMID:
16126242
20.

Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4.

Todaro M, Lombardo Y, Francipane MG, Alea MP, Cammareri P, Iovino F, Di Stefano AB, Di Bernardo C, Agrusa A, Condorelli G, Walczak H, Stassi G.

Cell Death Differ. 2008 Apr;15(4):762-72. doi: 10.1038/sj.cdd.4402305. Epub 2008 Jan 18.

Supplemental Content

Support Center